chrisvoncsefalvay/vaers-outcomes huggingface dataset:
He was admitted on 11/5/2021, until 11/7/2021. He had presented to the emergency department after his mother reported to us about the onset of increased breathing, followed by development of left-sided chest pain, and decreased energy several days after his Covid vaccine booster. He was afebrile, denied any cough, presyncope, syncope, complications. The symptoms of chest pain lasted for several days, and the rate of breathing continue to increase. During evaluation emergency department, he was found to have an elevated D-dimer, with a normal white blood cell count, and sinus tachycardia. He had a chest CT that was initially nondiagnostic, and subsequently repeated after being admitted. During the evaluation, he was found to have a left lower lobe consolidation/atelectasis concerning for effusion. Cardiac enzymes were negative, including a BNP that was normal. Chest CT repeat again demonstrated pleural effusion, with atelectasis, but no pulmonary embolus. Inflammatory markers were obtained, that were elevated. In addition echocardiogram was obtained, that demonstrated trivial pericardial effusion, with mildly decreased LV systolic function (baseline LVEF was 55% from 3/2021, decreased to approximately 51%) and no change of his bicuspid aortic valve function. He was started on NSAIDs and burst steroids. He was given a single dose of IV Lasix. With initiation of NSAIDs, he started to have less chest pain, and subsequent improved further before leaving the hospital.
was itchy; rash  at injection sight; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (rash  at injection sight) and VACCINATION SITE PRURITUS (was itchy) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038K20A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Feb-2021, the patient experienced VACCINATION SITE RASH (rash  at injection sight) and VACCINATION SITE PRURITUS (was itchy). The patient was treated with HYDROCORTISONE for Vaccination site pruritus, at an unspecified dose and frequency. At the time of the report, VACCINATION SITE RASH (rash  at injection sight) and VACCINATION SITE PRURITUS (was itchy) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.        No concomitant medications reported .  At the time of report, rash was bigger.  For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Patient reports having myalgia and Pain B/L Shoulder from the date of SHINGRIX administration which was in April. She was seen in Clinic on 06/25/18 and she has pain as mentioned above which is affecting her quality of life and ADL.
1 of 3 pts vaxed from the same vial who exp edema & redness @ inj site w/in 24hrs p/vax;this pt had rxn the size of an apple;no cultures taken;no cellulitis;treated w/cold packs
Symptoms of sever urticaria, head to toe, nausea, hives, chills.
Post vax, the pt lost all skills he had developed. Stopped using words, eating what he was eating or using the potty. He was not given any treatment and he was dx with autism.
Evening same day of shot muscles sore in arm around injection and overall body muscle achyness. Fatigue. Took Tylenol then next morning took Tylenol again and started getting a headache so by afternoon took Excedrin Migraine and by four in the afternoon all the symptoms were gone and haven't had any reoccurring symptoms
"NONOCCLUSIVE DVT RIGHT PERONEAL VEIN."  PT H/O CLOTTING DISORDER AND CHRONICALLY ON XARELTO 20 MG PER DAY PROPHYLAXIS, SINCE 2014. HAS BEEN TAKING MEDICATION REGULARLY.   NO KNOWN TRIGGER- DID COLD WATER SWIMMING 2 DAYS PRIOR TO ONSET OF SX (4/14/21) FEELS CONSTANT  ACHING IN RIGHT MID CALF AND TINGLING FEEL RIGHT MEDIAL LOWER LEG JUST BELOW KNEE.  STARTED WITH THE TINGLING/ BURNING FEEL RIGHT MEDIAL LOWER LEG BELOW KNEE 4/14/21, YESTERDAY (4/19) STARTED WITH CRAMPING PAIN MID RIGHT CALF JUST LIKE WHEN SHE HAS HAD DVTS IN THE PAST.   NO CP OR SOB.
Information has been received from a social media user via a market research referring to unspecified number of male patients of unknown age. On unknown dates the patients were vaccinated with GARDASIL (dose, strength and route were unknown). On unknown dates, the patient could not perform sexually and were hesitant to discuss their problem with parents. The patients might simply tell their parents that something was wrong down there. The patients' parents were advised to open their hearts about a formerly taboo subject and help their children times of the events. The outcome of the events was unknown. The reporter considered the events to be related to GARDASIL. This is one of several cases received from the same reporter. Additional information has been requested.
This spontaneous report was received from a registered nurse regarding a patient of unknown age and gender. The patient's medical history included breast cancer and lymph nodes removed. Patient's drug reactions or allergies were not provided. On 03-NOV-2015, the patient was vaccinated with an unspecified dose of ZOSTAVAX inadvertently in the abdominal instead of the recommended deltoid region (dose, route, lot number and expiration date were not provided). The patient also received an unspecified dose of Influenza virus vaccine (unspecified) in the deltoid in the right arm (dose, lot number and expiration date were not provided) administered on an unknown date and was unable to use the left arm as the patient had breast cancer and lymph nodes removed prior to receiving the 2 vaccines. No adverse effects were reported. At the time of the report, the patient's outcome was unknown. Causality was not provided. Additional information has been requested.
After receiving immunizations, PT went pale and passed out in chair, corpsman providing care helped PT to floor. PT recovered shortly after. PT was monitored VS and 2kg. Was released after about 30 mins.
This spontaneous report has been received from a licensed practical nurse referring to a unspecified patients of unknown ages and genders. Information regarding medical history, drug reactions, allergies, concomitant therapies and concurrent conditions was not provided. Since 03-JAN-2017, the unspecified patients were vaccinated with improperly stored doses ROTATEQ lot# M031650 and expiration date 16-MAR-2018, orally (strength, dose and frequency were unknown by the reporter), for prophylaxis. The reporter stated that the temperature excursion of the vaccine was 0 Celsius (C) to 2 Celsius (C) and the time frame was 10 hours, also she stated that the previous temperature excursion was not involved, this information was registered in a digital data logger. No adverse effect was reported. This is one of several cases received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1702USA011537: US-009507513-1702USA010881.
Pt's arm got swollen at the site of injection and also at the wrist the day after injection. Then the entire arm started hurting. Pt is unable hold anything in the arm. Pt experiences the pain a lot more at nights. Pt's physician also told her that white blood cells were elevated and her lymph nodes were swollen about a week later.
Cellulitis Injection Site; Infected Injection Site; Hard to the touch Injection Site; Itching Injection Site; Rash Injection Site; Red Injection Site; Swollen Injection Site; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE CELLULITIS (Cellulitis Injection Site), VACCINATION SITE INFECTION (Infected Injection Site), VACCINATION SITE INDURATION (Hard to the touch Injection Site), VACCINATION SITE PRURITUS (Itching Injection Site) and VACCINATION SITE RASH (Rash Injection Site) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 22-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Feb-2021, the patient experienced VACCINATION SITE PAIN (sore arm). On 01-Mar-2021, the patient experienced VACCINATION SITE CELLULITIS (Cellulitis Injection Site), VACCINATION SITE INFECTION (Infected Injection Site), VACCINATION SITE INDURATION (Hard to the touch Injection Site), VACCINATION SITE PRURITUS (Itching Injection Site), VACCINATION SITE RASH (Rash Injection Site), VACCINATION SITE ERYTHEMA (Red Injection Site) and VACCINATION SITE SWELLING (Swollen Injection Site). The patient was treated with CLINDAMYCIN at a dose of 300 milligram once a day. On 23-Feb-2021, VACCINATION SITE PAIN (sore arm) had resolved. At the time of the report, VACCINATION SITE CELLULITIS (Cellulitis Injection Site), VACCINATION SITE INFECTION (Infected Injection Site), VACCINATION SITE INDURATION (Hard to the touch Injection Site), VACCINATION SITE PRURITUS (Itching Injection Site), VACCINATION SITE RASH (Rash Injection Site), VACCINATION SITE ERYTHEMA (Red Injection Site) and VACCINATION SITE SWELLING (Swollen Injection Site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided.   Most recent FOLLOW-UP information incorporated above includes: On 02-Jul-2021: Event outcome updated
Information has been received from a healthcare worker referring to 3 patients of unknown age and gender. The patients' concurrent conditions and medical history were not reported. On an unknown date, the patients were vaccinated with improperly stored (Oka/Merck) VARIVAX (lot # L034367 with the expiration date 08-SEP-2017, dose and route were unknown). The patients' concomitant medication was not reported. No adverse effects reported. Additional information has been requested.
Patient received vaccination and shortly after patient started to feel dizzy. Patient then fainted for about 30 seconds then regained conciousness. Patient reported to feel hot after waking up. Otherwise back to normal.
PATIENT WAS INADVERTENTLY ADMINISTERED A 3RD BOOSTER DOSE OF ADULT PFIZER BIONTECH VACCINE WHEN SHE WAS UNDER 16. FOLLOWED UP WITH PATIENT'S MOTHER ON FOLLOWING DAY AND PATIENT HAS HAD NO ADVERSE EFFECTS.
Patient was feeling hot and appeared to be diaphoretic Pulse was 68 BPM, Respirations 12/minute Oxygen saturation 98% room air No c/o SOB and no difficulties breathing or swallowing Was given 250ml Orange juice and 200ml Water then another 150ml of soya milk within  a one hour period  Patient monitored closely with oversight by ARNP Patient felt improved and able to leave area approximately 2 hours later and was access last by ARNP
Nausea, diarrhea, fever, acute GI illness, abdominal cramping, dizziness, and disorientation from time of second pill administration.  Slight symptoms of stomach ache were noted about 36 hours after first pill was taken.  Pills were taken two hours after dinner, exactly 48 hours apart.  Patient felt so bad that she was taken to a physician on Monday 7/23.  Physician recommended immediate fluids and bed rest.  Physician said to discontinue use of Loperamide Hydrochloride tablets and let bowels empty.  Physician considered hospital admission and IV fluids.
pt recv vax;had adverse rxn complicated by panic attack;pt had inc thirst,flushed,dizziness;given meds;improved
20 min after vaccine reports dizziness and blurry vision she had the same thing with the first vaccine. BP138/78, HR 90, O2 sat 98% respirations/18 /min appears comfortable in cardiac chair c/o being to hot in auditorium.  denies SOB no facial swelling lungs clear no hives no CP. reports her lupus is bothering her and her joints. rested for 30 min , remained completely stable all sx resolved with in 5 min . rested in cardiac chair with ice packs felt well upon leaving
got a cold; tired for 24 hours; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (got a cold) and FATIGUE (tired for 24 hours) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Apr-2021, the patient experienced NASOPHARYNGITIS (got a cold) and FATIGUE (tired for 24 hours). On 24-Apr-2021, NASOPHARYNGITIS (got a cold) and FATIGUE (tired for 24 hours) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       Patient height reported as 5  8. No concomitant and treatment products were reported.    This case was linked to MOD-2022-481416, MOD-2022-481420 (Patient Link).
pt recv vax & 15min post vax pt exp tingling in arm & lips & tightness in chest;these sx were not treated & lasted 2-3 hr;pt reports that the tightness in chest was likely d/t exercising;
L sided Bell's palsy, 5 days of oral steroids.  2/19/08 Reviewed vax records & provider medical records which reveal patient in good health on 10/22/07.  Next vs 11/29 after ER vs 11/15 for left Bell's palsy.  Tx w/steroids & doing much better.  Reported no illness prior to onset of palsy.  T/C w/neuro who felt palsy probably due to varivax.   FINAL DX: Left side Bell's palsy.
his COVID PCR test came back positive; his COVID PCR test came back positive; This is a spontaneous report from a contactable consumer (patient's wife). A 66-year-old male patient received the unknown dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number and Expiry Date: not reported), via an unspecified route of administration on 27Aug2021 (Friday) as single dose for COVID-19 immunisation. Medical history included rheumatoid arthritis for which she was taking immunosuppressant medications. The patient's concomitant medications were not reported. On 01Sep2021 (Wednesday), the patient experienced COVID PCR test came back positive which was taken on Mon 30Aug. His wife had tested positive on 29Aug2021 (Sunday). He had no symptoms and felt fine. He had no fever no cold symptoms no weakness. Awareness date was 09Jan2021. The outcome of event was unknown.  The lot number for BNT162B2 was not provided and will be requested during follow up.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101148546 different patient, same drug and event
I started feeling congested, coughing, and wheezing. I suffered through that for about 2 months before I went to the doctor.  It was worse when I was laying down.
I got covid on sat night so i cancelled my last booster; I got covid on sat night so i cancelled my last booster; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from Regulatory Authority, Program ID:. The reporter is the patient.  A 66-year-old female patient received BNT162b2 (BNT162B2), as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "I got covid on sat night so i cancelled my last booster".  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Red painful rash 1 day after vaccine admin continues with 10 x 12cm red area to left upper arm, central area with induration.
flu shot 3PM lt deltoid & 312PM pt c/o difficulty swallowing & tightness p/flu shot; voice sounds hoarse; pt states feels itchy; 315PM given DPH; face flushed & pt thirsty;
Sore arm then developed later in the evening  chills muscle aches tiredness. The following day larger than a quarter  red arm reaction. Took  Ibuprofen & Benadryl
Pt exp redness & swelling of the arm of injection p/receiving Td; Seen in ER following day 9JUN91, but did not require tx;
Pt experienced shingles outbreak 1 week post-vaccine. Shingles outbreak was confirmed via dr's office. Shingles was on the left side (same side as the vaccine given). Left eye and left ear was affected due to outbreak.  Pt has never had an outbreak of shingles until after vaccine was given. Pt was treated for shingles with valacyclovir 1mg three times daily for 7 days.
MAGNET STICKING TO VACCINATION SITE; This spontaneous report received from a consumer concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 26-MAY-2021, the subject experienced magnet sticking to vaccination site. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of magnet sticking to vaccination site was not reported. This report was non-serious. This case, from the same reporter is linked to 20210555852.
broke out in rash this AM, mom suspected chicken pox so brought pt in was dx w/chicken pox & zovirax prescribed;
had shingles vaccine and still got a mild case/Suspected Vaccination Failure; got a mild case; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: had shingles vaccine and still got a mild case/Suspected Vaccination Failure) (serious criteria GSK medically significant) and shingles (Verbatim: got a mild case). The outcome of the vaccination failure was unknown and the outcome of the shingles was resolved (duration 3 weeks).   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.   It was unknown if the company considered the vaccination failure and shingles to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 23-MAR-2023 This case was reported by a patient via interactive digital media. The patient had his/her shingles vaccine and still got a mild case of shingles for three weeks. The doctor said that it would have worse if he/she did not get the shingles vaccine. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting. The follow up would not possible as no contact details were available.
Headache; fatigue; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache), FATIGUE (fatigue) and NAUSEA (Nausea) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Acid reflux (oesophageal). Concomitant products included ABALOPARATIDE (TYMLOS) from 04-Nov-2021 to an unknown date for an unknown indication.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HEADACHE (Headache), FATIGUE (fatigue) and NAUSEA (Nausea). The patient was treated with IBUPROFEN for Headache, at an unspecified dose and frequency. At the time of the report, HEADACHE (Headache), FATIGUE (fatigue) and NAUSEA (Nausea) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
I started experiencing heart palpitations that lasted for days at a time at the end of May 2021/beginning of June 2021. After several weeks where the palpitations continued, I sought treatment where they diagnosed this and saw that my heart is prematurely beating and then pausing to reset itself. On 6/24/2021 I went to the ER on advice from my doctor. From what they say, there is not really a treatment for these symptoms and I will just have to wait and see if they go away. At this reporting time, they are still ongoing. I'm to follow up with my family medicine doctor.
Extremely lightheaded, dizzy, blurred vision, temporary loss of hearing in one ear; resolved itself within another 10 minutes.  (so far, it's been just 6 hrs since the shot).
Disequilibrium; This is a spontaneous report from a contactable nurse (patient).  This 38-years-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), intramuscular, on 18Dec2020 at 04:00 PM at single dose for COVID-19 immunisation. Vaccine location was right arm.  The patient was vaccinated at hospital, age at vaccination was 38-years-old. No other vaccine was received in four weeks. Medical history was none. Concomitant medications were unknown. On 20Dec2020, the patient experienced disequilibrium. The event was reported as non-serious. The patient was tested for Covid post vaccination through a nasal swab on 20Dec2020, results are unknown. Outcome was recovering. No treatment was received for the event. Information on the lot/batch number has been requested.
Initial report received on 06 October 2009 from a health professional. A 54 year old male patient, with a history of high cholesterol, received a first left deltoid intramuscular injection of an H1N1 (Sanofi Pasteur, lot number not reported) on 01 October 2009 at 03:15 p.m. Concomitant medication included ZOCOR and vitamins. He had no illness at the time of vaccination. The patient had previously received a first left deltoid intramuscular injection of FLUZONE (lot number not reported) on 10 September 2009. The patient had no adverse event following prior vaccination. On 01 October 2009, at approximately 07:00 p.m, the patient developed a headache, chills, sweats and body aches which lasted 2.5 days. The patient also had left arm soreness. Corrective treatment was not reported. The patient recovered.
Patient's age written as 12 on consent signed by person identifying as patient's father. Upon research, patient's date of birth is different; therefore too young for vaccine.
patient ambulated to the observation area after receiving the COVID-19 Moderna vaccine and experienced what appeared to be a syncopal episode that lasted for approximately 10 seconds with incontinence.  Patient stated "everything went black".  He said this has happened to him every time he has a blood draw or an injection but this is the first time he was incontinent.  vital signs were stable throughout event.  Transferred to local hospital by emergency medical responders and emergency vehicle.
developed cellulitis in his left arm.  Had some pre-existing swelling he reports, but worsened two days after the vaccination
Case number PHEH2014US021403, is an initial spontaneous report received from a consumer on 23 OCT 2014. This case refers to a patient of unspecified age and gender. Past medical history and concomitant medication were not reported. The patient was vaccinated with FLUVIRIN 2014/2015 (batch number: not reported), intramuscularly on 23 OCT 2014, which was stored at 60 F for 24 hours. No adverse event was reported following this administration error (incorrect storage of drug).
Vomiting began 8/9/22, one day after testing positive with home test.  Vomiting continued and went to Emergency Room on 8/10/22  where I was given IV fluids as I was dehydrated. Discharged the same day.
My dad died 2 days after 2nd maderna dose he was healthy he still worked full time